Illumina, Inc. is an American company incorporated in April 1998 that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serve the sequencing, genotyping and gene expression and proteomics markets. Its headquarters are located in San Diego, California.
Wikipedia
The increased ease of next-generation sequencing (NGS) means more data to interpret than ever before. The process for variant annotation, curation, and interpretation can be extremely cumbersome. The Illumina BaseSpace Variant Interpreter is an online interpretation and reporting platform designed to streamline your workflow. Learn how to gain biological insight from genomic data at https://www.i...
In 2014, the world’s eyes were pointed towards West Africa, where an Ebola outbreak was claiming the lives of thousands of people, including caregivers and laboratory workers. However, long before that, the virus was already quietly circulating. By the time the virus had been identified, the outbreak was hard to contain, and it led to devastating consequences. To understand how to prevent this fro...
Our daily activities and agriculture can take a heavy toll on our environment. Dr. Sharon Doty, from the School of Environmental and Forest Sciences at the University of Washington, hopes to use plant-microbe partnerships to revolutionize the fields of agriculture, forestry, and bioenergy by making them more environmentally and economically sustainable. In this episode, Jacques and Irene traveled ...
Career journey in a word: Blissful Clotilde came to Illumina as a product manager in 2012. Today, she is a senior market development manager and enjoys working as part of the Microbiology team to understand the genome of the bacteria that live on us and in us. Listen as Clotilde explains what makes her career journey blissful and what brought her to Illumina.
Career journey in a word: Unexpected Gemma began her journey with Illumina as a lab assistant within Microarray Production in 2014. In her current role as a quality assurance engineer, she helps to ensure we deliver excellent products to our customers. Listen as Gemma shares why she chose Illumina and how she managed her career journey to land her current role.
Career journey in a word: Fast Donalda joined Illumina as an inside sales representative covering the Nordics and Baltics region in 2015. She has since grown into the role of territory account manager supporting London. In her video, Donalda shares the surprising way she came to know Illumina and one thing she could not do anywhere else but here.
Career journey in a word: High Speed Dominic came to Illumina in 2016 to kick off his career as a research associate. As part of the Product Development team within R+D, Dominic focuses on the development and robustness of our reagent and assay instruments. Check out the video to learn more about Dominic’s role and what compelled him to pursue a career with Illumina.
Create custom content on the AmpliSeq for Illumina solution—the new workflow for your targeted next-generation sequencing (NGS) studies. Learn how to design custom panels with our DesignStudio software, a free and easy-to-use tool that allows you to create custom enrichment and amplicon designs. Design panels from 12 to more than 12,000 amplicons, in general up to 4 pools. Watch how in this step-b...
Simplify data analysis on the AmpliSeq for Illumina solution—the new workflow for your targeted next-generation sequencing (NGS) studies. Learn how to analyze, store, and share your data using BaseSpace Sequence Hub, our economical, powerful computing environment. Watch how in this step-by-step guide. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=Illu...
Accelerate your research with the AmpliSeq for Illumina solution—the new workflow for your targeted next-generation sequencing (NGS) studies. Learn how to perform on-premises amplicon analysis using the Illumina Local Run Manager. Watch how simple and easy it is to analyze your targeted sequencing data in this step-by-step guide. Subscribe to the Illumina video channel http://www.youtube.com/sub...
Accelerate your research with the AmpliSeq for Illumina solution—the new workflow for your targeted next-generation sequencing (NGS) studies. Quickly identify, annotate, and classify disease-relevant variants and summarize significant findings in one report using BaseSpace Variant Interpreter. The tool integrates with BaseSpace Sequence Hub to enable quick identification and classification of dise...
The latest addition to the Illumina library prep portfolio, the AmpliSeq for Illumina solution provides a simple, fast, and robust amplicon sequencing option to achieve high-confidence data from even low-quality DNA and RNA samples. Combining industry-leading AmpliSeq chemistry with the sequencing power of Illumina and push-button bioinformatics, targeted resequencing has never been so simple. Thi...
Leaders from Illumina and Thermo-Fisher Scientific discuss their collaboration on AmpliSeq for Illumina, the latest in amplicon sequencing. Hear them share insights on the partnership and their commitment to creating a flexible solution for customers.
Introducing the iSeq 100, the latest advancement in the world of next-generation sequencing (NGS) from Illumina. The iSeq 100 instrument leverages Illumina technological advances in its smallest and most accessible system to date. Building on trusted sequencing by synthesis (SBS) chemistry and combining it with the latest single channel complementary metal-oxide-semiconductor (CMOS) detection tech...
The world population is continuously growing. As the second largest producer and largest exporter of beef in the world, Brazil has an important role in feeding such a population. Jacques and Irene from our Scientific Affairs team met with José Fernando Garcia, Professor of Genomics at Sao Paulo State University, and other advocates of the use of genomic selection. Hear their thoughts on how to imp...
Alzheimer’s Disease is characterized by the presence of plaques and tangles inside an individual’s brain. Subscribe to Illumina: http://bit.ly/IlluminaYouTube Despite this clear pathological definition, the predisposing factors and effects of these plaques and tangles are unclear. On this Adventures in Genomics episode, Jacques and Irene speak to Amanda Myers from the University of Miami, who is ...
Sophia and her family spent years in search of a diagnosis for her condition. Finally, a de novo mutation was discovered through a clinical whole genome sequencing (cWGS) test she received from the Illumina iHope Network. Hear her parents, her geneticist Dr Christian Schaaf of Baylor College of Medicine, and Illumina Senior Medical Scientist Dr John Belmont discuss what it means to have a diagnosi...